Cancer Focus Fund BRF is a venture capital firm.
It has taken part in 1 funding round across 1 Israeli company1.
Most recent: Starget Pharma’s Series A of $18M1, announced Feb 18, 2026.
Israeli rounds
| Feb 18, 2026 | Starget Pharmabiotech, healthtech | Series A | $18M | Participant |
Israeli portfolio
Who invests alongside Cancer Focus Fund BRF?
Sources
- 1CTech, Feb 18, 2026. “Israeli biotech Starget secures $18 million Series A to accelerate precision cancer treatments”
Which Israeli startups has Cancer Focus Fund BRF invested in?
Cancer Focus Fund BRF has invested in Starget Pharma.
How many rounds has Cancer Focus Fund BRF led?
Cancer Focus Fund BRF has not led any of the 1 round it joined.
What was Cancer Focus Fund BRF’s most recent Israeli investment?
Starget Pharma’s Series A of $18M, announced Feb 18, 2026.